How to monitor safety and efficacy of biologic treatment in rare, therapy-refractory immune-mediated inflammatory diseases?
Amsterdam Rheumatology and Immunology Center, Academic Medical Center (AMC)/University of Amsterdam, The Netherlands.
Anne
A
Musters
Amsterdam Rheumatology and Immunology Center, Academic Medical Center (AMC)/University of Amsterdam, The Netherlands.
Sander W
SW
Tas
D001685:Biological Factors / Q000627:therapeutic use*; D001688:Biological Products / Q000627:therapeutic use*; D006801:Humans; D007154:Immune System Diseases / Q000188:drug therapy*; D035583:Rare Diseases; D016896:Treatment Outcome
D001685:Biological Factors; D001688:Biological Products